EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

New Benzofuran–Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies

Somaia S Abd El-Karim iD, Manal M Anwar, Yasmin M Syam iD, Hassan M Awad iD, Asmaa Negm El-Dein iD, Mohamed K El-Ashrey iD, Hamad M Alkahtani iD, Sameh H Abdelwahed iD

Pharmaceuticals · 10.12.2024 · 17 (12) · 1664

DOI: 10.3390/ph17121664 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 10.12.2024. Verfasst von Somaia S Abd El-Karim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Researchers Supporting Project number (RSPD2024R930), King Saud University, Riyadh, Saudi Arabia, King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The alarming rise in antibiotic resistance necessitates the discovery of novel antimicrobial agents. This study aims to design, synthesize, and evaluate new benzofuran–pyrazole-based compounds for their antimicrobial, antioxidant, and anti-inflammatory properties.

Methods

New benzofuran–pyrazole hybrid molecules were synthesized using the Vilsmeier–Haach reaction and other chemical processes. The structures of the synthesized compounds were confirmed through micro-analytical and spectral analyses. Their antimicrobial activities were assessed against various bacterial and fungal strains, while antioxidant and anti-inflammatory properties were evaluated using DPPH-free radical scavenging and HRBC membrane stabilization assays, respectively. The most promising compounds were further tested for DNA gyrase B inhibition.

Results

Compounds 9, 10, and 11b–d exhibited significant broad-spectrum antimicrobial activity with MIC values ranging from 2.50 to 20 µg/mL. Compounds 4, 6, 9, 11b, and 11d demonstrated high antioxidant activity, with DPPH scavenging percentages between 84.16% and 90.52%. Most compounds showed substantial anti-inflammatory effects, with HRBC membrane stabilization percentages ranging from 86.70% to 99.25%. Compound 9 notably inhibited E. coli DNA gyrase B with an IC50 of 9.80 µM, comparable to ciprofloxacin.

Conclusions

The benzofuran–pyrazole-based compounds, particularly compound 9, show great potential as new antimicrobial agents due to their broad-spectrum activity and potent DNA gyrase B inhibition. These findings support further development and optimization of these compounds for clinical applications.

Schlagwörter

Stichwörter der Autor:innen

antimicrobial activityantioxidantbenzofuran–pyrazole scaffoldcomputational studiesin vitro anti-inflammatory DNA gyrase enzyme

Autor:innen und Institutionen

  • Department of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
  • Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Cairo 12622, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr Elini St., Cairo 11562, Egypt.
  • Medicinal Chemistry Department, Faculty of Pharmacy, King Salman International University (KSIU), South Sinai 46612, Egypt.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Department of Chemistry, Prairie View A&M University, Prairie View, TX 77446, USA.

ORCID-Profile: Somaia S Abd El-Karim, Yasmin M Syam, Hassan M Awad, Asmaa Negm El-Dein, Mohamed K El-Ashrey, Hamad M Alkahtani, Sameh H Abdelwahed

Förderung

  • Researchers Supporting Project number (RSPD2024R930), King Saud University, Riyadh, Saudi Arabia
  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Abd El-Karim, S. S., Anwar, M. M., Syam, Y. M., Awad, H. M., El-Dein, A. N., El-Ashrey, M. K., Alkahtani, H. M., & Abdelwahed, S. H. (2024). New Benzofuran–Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies. Pharmaceuticals, 17(12), 1664. https://doi.org/10.3390/ph17121664

Vancouver

Abd El-Karim SS, Anwar MM, Syam YM, Awad HM, El-Dein AN, El-Ashrey MK, et al. New Benzofuran–Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies. Pharmaceuticals. 2024;17(12):1664. doi:10.3390/ph17121664

BibTeX
@article{AbdElKarim2024,
  author = {Abd El-Karim, Somaia S and Anwar, Manal M and Syam, Yasmin M and Awad, Hassan M and El-Dein, Asmaa Negm and El-Ashrey, Mohamed K and Alkahtani, Hamad M and Abdelwahed, Sameh H},
  title = {New Benzofuran–Pyrazole-Based Compounds as Promising Antimicrobial Agents: Design, Synthesis, DNA Gyrase B Inhibition, and In Silico Studies},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {12},
  pages = {1664},
  doi = {10.3390/ph17121664}
}
Kostenlos starten →